Gene therapy for children with sickle cell disease approved by FDA

From The Hill

A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug Administration.

Source Author
Author: Source Author

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *